CARDIOTOXICITY
Clinical trials for CARDIOTOXICITY explained in plain language.
Never miss a new study
Get alerted when new CARDIOTOXICITY trials appear
Sign up with your email to follow new studies for CARDIOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Exercise prescription to shield Survivors' hearts
Disease control Not yet recruitingThis study is testing whether a supervised exercise program can help protect the hearts of breast cancer survivors. Many life-saving cancer drugs can damage the heart over time. Researchers will compare heart health in women who complete a 16-week exercise program against those w…
Matched conditions: CARDIOTOXICITY
Phase: NA • Sponsor: University of Castilla-La Mancha • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC
-
New computer aid aims to shield cancer survivors from heart damage
Disease control Not yet recruitingThis study is testing a new computer-based decision tool designed to help doctors better protect cancer survivors from heart problems. The tool will be tested with 60 cancer survivors who are at risk for heart disease. Researchers want to see if the tool is easy for doctors and p…
Matched conditions: CARDIOTOXICITY
Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Can exercise heal the hearts of childhood cancer survivors?
Disease control Not yet recruitingThis study aims to find out if exercise can help improve heart health in young adults who survived childhood cancer. It will compare two types of exercise training—high-intensity intervals versus moderate continuous workouts—to see which is more effective. About 20 participants w…
Matched conditions: CARDIOTOXICITY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
AI vs. MRI: the race to spot Chemo's hidden heart damage
Diagnosis Not yet recruitingThis study aims to see if new artificial intelligence (AI) software can improve heart scans for people receiving chemotherapy. It will compare two AI systems against standard heart ultrasound and cardiac MRI in 120 patients to see which method is most accurate at detecting early …
Matched conditions: CARDIOTOXICITY
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC
-
Tracking the hidden heart risks of Life-Saving cancer treatment
Knowledge-focused Not yet recruitingThis study aims to understand why and how heart problems develop in patients receiving stem cell transplants for blood cancers. Researchers will follow 400 transplant patients for one year, using heart scans, blood tests, and health tracking to identify early warning signs of hea…
Matched conditions: CARDIOTOXICITY
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC